ID.1
Item
age >17
boolean
ID.2
Item
pulmonary arterial hypertension (pah) associated with who group 1 who start a parenteral prostanoid-therapy
boolean
ID.3
Item
written informed consent
boolean
ID.4
Item
prostanoid naive
boolean
ID.5
Item
no change of the pah specific therapy within 3 weeks of the recruitment to the study
boolean
ID.6
Item
pregnancy and lactation period
boolean
ID.7
Item
women of child bearing potential who do not use an effective and secure method for birth control
boolean
ID.8
Item
severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
boolean
ID.9
Item
liver-insufficiency child c
boolean
ID.10
Item
life expectancy shorter than the course of the study (for example because of malignant disease
boolean